• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

截短型组织金属蛋白酶抑制剂δ128 - 194(TIMP - 2)的结晶及初步X射线分析

Crystallization and preliminary X-ray analysis of a truncated tissue metalloproteinase inhibitor delta 128-194 TIMP-2.

作者信息

Tolley S, Murphy G, O'Shea M, Ward R, Docherty A, Cockett M, Rawas A, Davies G

机构信息

Department of Chemistry, University of York, Heslington, U.K.

出版信息

J Mol Biol. 1993 Feb 20;229(4):1163-4. doi: 10.1006/jmbi.1993.1114.

DOI:10.1006/jmbi.1993.1114
PMID:8445644
Abstract

Crystals of an active truncated form of a human tissue metallproteinase inhibitor (delta 128-194 TIMP-2), a protein implicated in a number of diseases of the connective tissues, have been grown in a form suitable for study by X-ray diffraction analysis. Crystals grow using polyethylene glycol 600 as a precipitant and are in space group P2(1)2(1)2, with cell dimensions a = 75.28 A, b = 100.77 A, c = 31.45 A. The asymmetric unit appears to contain two molecules of delta TIMP-2 with a Vm value of 2.3 A3/dalton. The crystals diffract to Bragg-spacings beyond 2.5 A. Native data to 3.2 A have been collected and a search for heavy-metal derivatives is in progress.

摘要

人组织金属蛋白酶抑制剂(δ128 - 194 TIMP - 2)活性截短形式的晶体已经生长出来,该蛋白质与多种结缔组织疾病有关,其晶体形态适合用于X射线衍射分析研究。晶体生长使用聚乙二醇600作为沉淀剂,属于空间群P2(1)2(1)2,晶胞参数a = 75.28 Å,b = 100.77 Å,c = 31.45 Å。不对称单元似乎包含两个δTIMP - 2分子,Vm值为2.3 Å3/道尔顿。这些晶体的衍射极限可达2.5 Å以上。已经收集了分辨率至3.2 Å的天然数据,并且正在寻找重金属衍生物。

相似文献

1
Crystallization and preliminary X-ray analysis of a truncated tissue metalloproteinase inhibitor delta 128-194 TIMP-2.截短型组织金属蛋白酶抑制剂δ128 - 194(TIMP - 2)的结晶及初步X射线分析
J Mol Biol. 1993 Feb 20;229(4):1163-4. doi: 10.1006/jmbi.1993.1114.
2
Crystallization and preliminary X-ray analysis of nonglycosylated tissue inhibitor of metalloproteinases-1, N30QN78Q TIMP-1.非糖基化金属蛋白酶组织抑制剂-1(N30QN78Q TIMP-1)的结晶及X射线初步分析
Proteins. 1993 Dec;17(4):435-7. doi: 10.1002/prot.340170410.
3
Crystallization and preliminary X-ray analysis of Candida albicans phosphomannose isomerase.白色念珠菌磷酸甘露糖异构酶的结晶及初步X射线分析
J Mol Biol. 1994 Apr 1;237(3):349-50. doi: 10.1006/jmbi.1994.1235.
4
Crystallization and preliminary X-ray crystallographic analysis of alpha-amylase from Bacillus subtilis.枯草芽孢杆菌α-淀粉酶的结晶及初步X射线晶体学分析
J Mol Biol. 1993 Jan 5;229(1):235-8. doi: 10.1006/jmbi.1993.1020.
5
Crystallization and preliminary X-ray analysis of Streptococcus pneumoniae hyaluronate lyase.肺炎链球菌透明质酸裂解酶的结晶及初步X射线分析
J Struct Biol. 1998 Jan;121(1):73-5. doi: 10.1006/jsbi.1998.3963.
6
Crystallization and preliminary X-ray crystallographic analysis of arylesterase from Pseudomonas fluorescens.荧光假单胞菌芳基酯酶的结晶及初步X射线晶体学分析
Proteins. 1993 Feb;15(2):213-5. doi: 10.1002/prot.340150212.
7
Crystallization and preliminary X-ray diffraction studies of leishmanolysin, the major surface metalloproteinase from Leishmania major.硕大利什曼原虫主要表面金属蛋白酶利什曼溶素的结晶及初步X射线衍射研究。
Proteins. 1995 May;22(1):58-66. doi: 10.1002/prot.340220109.
8
Crystallization and preliminary X-ray crystallographic analysis of probable amylase/protease inhibitor-B from rice seeds.水稻种子中可能的淀粉酶/蛋白酶抑制剂-B的结晶及初步X射线晶体学分析。
J Mol Biol. 1993 Jan 5;229(1):255-7. doi: 10.1006/jmbi.1993.1027.
9
Crystallization and preliminary X-ray crystallographic analysis of the protease inhibitor ecotin.蛋白酶抑制剂依科汀的结晶及初步X射线晶体学分析
J Mol Biol. 1993 Feb 20;229(4):1157-8. doi: 10.1006/jmbi.1993.1112.
10
Crystallization and preliminary X-ray diffraction studies of the soluble 14 kDa beta-galactoside-binding lectin from bovine heart.牛心可溶性14 kDaβ-半乳糖苷结合凝集素的结晶及初步X射线衍射研究。
J Mol Biol. 1994 Jan 14;235(2):787-9. doi: 10.1006/jmbi.1994.1034.

引用本文的文献

1
Blocking cartilage destruction with metalloproteinase inhibitors: a valid therapeutic target?用金属蛋白酶抑制剂阻断软骨破坏:一个有效的治疗靶点?
Ann Rheum Dis. 1993 Nov;52(11):769-70. doi: 10.1136/ard.52.11.769.